AI in personalized cancer medicine: New therapies require flexible and safe approval conditions
New, AI-based therapies require a flexible and safe legal framework in order to reach patients quickly and safely. In a new paper, published in npj Precision Oncology, researchers from Dresden, Leipzig, Marburg and Paris ...